
Loading, please wait...

Loading, please wait...

Researchers recently developed a novel approach using chloramphenicol transfersome delivery to treat eye infections. Specifically, they focused on applying these formulations directly onto the eyelid skin. Consequently, this method aims to bypass traditional ocular barriers. Furthermore, the study utilized transfersomes with an average size of 120 nm. Because these vesicles are monodispersed, they ensure uniform drug distribution. Moreover, this innovation could revolutionize how we manage bacterial conjunctivitis in clinical settings.
These ultra-deformable vesicles offer several clinical advantages. However, traditional eye drops often wash away quickly. In contrast, transfersomes penetrate the eyelid skin to reach the conjunctiva. Therefore, this system provides a sustained therapeutic effect. Additionally, the non-invasive nature improves patient compliance significantly. Ultimately, clinicians can expect better outcomes with reduced dosing frequency.
The skin of the eyelid acts as a gatekeeper for topical medications. Similarly, the unique composition of transfersomes allows them to squeeze through the stratum corneum. Hence, the drug reaches the infection site without direct irritation to the eyeball. Notably, this method reduces systemic side effects by focusing on local delivery. As a result, it provides a safer alternative for sensitive populations like children.
Transfersomes contain edge activators that make them ultra-deformable. Consequently, they can squeeze through tiny pores in the skin more effectively than rigid liposomes. This enhances drug penetration significantly.
Eyelid application allows the drug to penetrate the skin and reach the conjunctiva locally. Therefore, it reduces the discomfort and rapid drainage issues associated with traditional eye drops. This ensures a higher concentration of the drug stays at the target site.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Grygor'yeva L et al. Chloramphenicol Application Onto the Eyelid: Transfersomes for Enhanced Skin Delivery. AAPS PharmSciTech. 2026 Jun 11. doi: undefined. PMID: 42277546.
Vyavahare SS, et al. Chloramphenicol Overview in Eye Infections. International Journal of Pharmacy & Pharmaceutical Research. 2024; 30(5): 72-84.
Dua A, et al. Transfersomes: A Vesicular Tool for Transdermal Drug Delivery. Innovative Lipid-Based Vesicles. 2026.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed chloramphenicol-loaded transfersomes (120 nm) to treat conjunctivitis via eyelid application. This novel delivery system enhances drug permeability and stability, offering a promising non-invasive alternative to traditional eye drops for managing ocular infections.
2 months ago

A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today

A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today

A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday

The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today